Andrew Iott Named HAPPE Spine President and CEO

There’s a new leader in charge at HAPPE Spine.

The company has hired Andrew Iott as president and CEO. Iott brings more than 20 years of experience in medical device product development and commercialization to his new role, with extensive knowledge of the spine market. As co-founder of Globus Medical, Iott played a critical role in taking the company from a startup to a worldwide leader in orthopedics.
 
“The fact that HAPPE has landed an experienced executive like Mr. Iott clearly speaks volumes for our value proposition,” HAPPE Spine Founder/Chief Technology Officer Dr. Ryan K. Roeder said.
 
HAPPE develops next-generation orthopedic and spinal implants enabled by the HAPPE (HydroxyApatite Porous PolyEtheretherketone) platform. The HAPPE material platform offers interconnected, cancellous porosity with exposed hydroxyapatite on pore surfaces to enable robust bone in-growth and on-growth confirmed in preclinical testing.
 
“I am very excited to join the HAPPE Spine management team and continue the development of this platform. The superior bone healing environment afforded by optimum biomechanical properties and a porous microstructure, that is fully integrated with hydroxyapatite, is a clear advancement in orthopedics,” Iott said. “I’m convinced the spine and broader orthopedic industry are looking for implants that make a leap forward in material science to provide an enhanced platform for osteointegration and HAPPE is that material. I am looking forward to working with this team to launch market disrupting products.”
 
HAPPE is preparing to enter the market with the INTEGRATE-C, a cervical interbody spinal fusion cage, to establish clinical efficacy.
 
HAPPE Spine LLC designs and commercializes orthopedic and spinal implants utilizing the patented HAPPE material platform, which transforms polyetheretherketone from a hydrophobic, bioinert, and non-integrating material into a hydrophilic and osteointegrating material, confirmed by robust bone in-growth and on-growth in preclinical testing. The HAPPE INTEGRATE interbody spinal fusion system is the first to offer bone-like cancellous porosity with exposed hydroxyapatite on the pore surfaces, as well as porosity extending across the entire implant height to promote endplate-to-endplate osteointegration. INTEGRATE is designed to promote both load bearing and healing, as well as superior post-operative imaging. The HAPPE INTEGRATE interbody fusion system thus offers allograft-like qualities in a synthetic implant that can improve clinical outcomes in interbody spinal fusion by overcoming the problems of pseudoarthrosis, subsidence and imaging artifacts that limit current PEEK and titanium implants.